Yüklüyor......
The Application of CAR-T Cells in Haematological Malignancies
Chimeric antigen receptor (CAR)-T cells (CART) remain one of the most advanced and promising forms of adoptive T-cell immunotherapy. CART represent autologous, genetically engineered T lymphocytes expressing CAR, i.e. fusion proteins that combine components and features of T cells as well as antibod...
Kaydedildi:
| Yayımlandı: | Arch Immunol Ther Exp (Warsz) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7647970/ https://ncbi.nlm.nih.gov/pubmed/33156409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00005-020-00599-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|